Search
Showing results for "1"
News & Events
Meet Perth's final ENDIA participantAustralia’s biggest study into the causes of type 1 diabetes reached a significant milestone when its last Perth-based participant was born recently.
News & Events
Jazmyn's journey beginsTen-year-old Jazmyn Kalin’s diabetes journey may have only just begun but she is taking it all in her stride, administering her own insulin needles and even learning about carbs.
News & Events
Testing how much protein is needed to prevent overnight hypos which can happen after exerciseWe're testing how much protein is needed to prevent overnight hypos which can happen after exercise
Research
Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 yearsWe provide new evidence to support current guidelines for orchidopexy before age 18 months to decrease the risk of future testicular cancer and infertility
Find newsletters, guidelines, publications and videos in the one spot.
Research
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as ToddlersOne dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY
Research
Gestational weight gain charts for different body mass index groups for women in Europe, North America, and OceaniaGestational weight gain patterns are strongly related to pre-pregnancy body mass index
News & Events
Healthcare Transition SupportHEALTHCARE TRANSITION STUDY Co-designing transition support: Phase 1 For young people with type 1 diabetes (T1D), growing up means moving from child
Research
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIVTo evaluate the safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F, 22F, 23F, 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in children with HIV.
News & Events
Protein, exercise and hypo studyFor this study, we want to see how much protein is necessary to prevent overnight hypos without causing high blood glucose levels.